MedTrace Logo

Influence of Frailty on Cardiovascular Events and Mortality in Patients With COPD.

NCT05922202 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 300

Last updated 2025-08-05

No results posted yet for this study

Summary

Observational study on the influence of frailty on cardiovascular risk in COPD.

Conditions

  • Role of Frailty in COPD

Interventions

OTHER

Assessment of cardiovascular events, cardiovascular mortality, all-cause mortality, and mortality due to COPD at 12 and 24 months

At 12 and 24 months of follow up, cardiovascular events (including hospital admissions), deaths due to cardiovascular disease, deaths due to all-cause, deaths due to COPD will be recorded in COPD outpatients group.

Sponsors & Collaborators

  • Campus Bio-Medico Universitario di Roma-Medicina Interna - Servizio di Pneumologia

    collaborator UNKNOWN

  • Ospedale Sant'Andrea - Azienda Sanitaria Locale di Vercelli-Reparto di Pneumologia

    collaborator UNKNOWN

  • Hospitals - Aneurin Bevan University Heath Board (Wales) - United Kingdom

    collaborator UNKNOWN

  • Azienda Ospedaliero-Universitaria di Modena

    lead OTHER

Principal Investigators

  • Alessia Verduri, PhD · Respiratory Unit-University of Modena (Italy) - Hospital Policlinico Modena

  • Alessia Verduri, PhD · Respiratory Unit-University of Modena (Italy)-Hospital Policlinico Modena

Eligibility

Min Age
40 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-02-23
Primary Completion
2025-11-15
Completion
2026-06-30

Countries

  • Italy

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05922202 on ClinicalTrials.gov